Article information
Full text is only aviable in PDF
Bibliografía
[1.]
J.M. Rommens, M.C. Iannuzzi, B. Kerem, M.L. Drumm, G. Melber, M. Dean, et al.
Identification of cystic fibrosis gene: chromosome walking and jumping.
Science, 245 (1989), pp. 1059-1065
[2.]
J.D. Acton, J.M. Stark.
Management of acute exacerbations of cystic fibrosis lung disease.
Clin Pulm Med, 6 (1999), pp. 153-164
[3.]
B.C. Marsall.
Pathophysiology of pulmonary disease in cystic fibrosis.
Semin Respir Crit Care Med, 15 (1994), pp. 364-374
[4.]
B.W. Ramsey.
Management of pulmonary disease in patients with cystic fibrosis.
N Engl J Med, 335 (1996), pp. 179-188
[5.]
B.C. Marshall, W. Samuelson.
Basic therapies in cystic fibrosis Does standard therapy work?..
Clin Chest Med, 19 (1998), pp. 487-504
[6.]
P.B. Davis, M. Drumm, M.W. Konstan.
Cystic fibrosis.
Am J Respir Crit Care Med, 154 (1996), pp. 1229-1256
[7.]
Practical guidelines for cystic fibrosis care,
[8.]
J.D. Eisemberg.
Antibiotic use in cystic fibrosis.
Curr Opin Pulm Med, 2 (1996), pp. 439-446
[9.]
Grupo de trabajo “Fibrosis Quística” (Sociedad Española de Neumología, Pediátrica)..
Protocolo de diagnóstico y seguimiento de. los enfermos con fibrosis quística.
An Exp Pediatr, 50 (1999), pp. 625-634
[10.]
Clinical P ractice Guidelines for Cystic Fibrosis.
Treatment of pulmonary exacerbation of cystic fibrosis., CF Founation, (1997), pp. 27-29
[11.]
M.A. Donati, G. Guenette, H. Auervach.
Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary. disease.
J Pediatr, 111 (1987), pp. 28-33
[12.]
J.M. Wolter, S.D. Bowler, P.J. Nolan, J.G. McCormack.
Home intravenous therapy in cystic fibrosis: a prospective randomized trial examing clinical, quality of life, and cost aspects.
Eur Respir J, 10 (1997), pp. 896-900
[13.]
D.J. Bosworth, D.W. Nielson.
Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis.
Pediatr Pulmonol, 24 (1997), pp. 42-47
[14.]
R. Gold, S. Carpenter, H. Heurter, M. Corey, H. Levinson.
Randomized trial of ceftazidime versus placebo in the management of acute exacerbations in patients with cystic fibrosis.
J Pediatr, 111 (1987), pp. 907-913
[15.]
R.E. Wood.
What is a “pulmonary exacerbation” in cystic fibrosis?.
J Pediatr, 111 (1987), pp. 841-842
[16.]
W.E. Regelmann, G.R. Elliott, W.J. Warwick, C.C. Clawson.
Reduction of sputum Pseudomonas aeruginosa density by antibiotics. improves lung function in cystic fibrosis more than do bronchodilators and chest phisiotherapy alone.
Am Rev Respir Dis, 141 (1990), pp. 914-921
[17.]
S.V. Turpin, M.R. Knowles.
Treatment of pulmonary disease in patients with cyscic fibrosis..
pp. 277-344
[18.]
B.W. Ramsey, K.R. Wentz, A.L. Smith, M. Richardson, P. Williams-Warren, D.L. Hedges, et al.
Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients.
Am Rev Respir Dis, 144 (1991), pp. 331-337
[19.]
L. Saiman, W. Niu, A. Prince, H. Neu.
A referral center to study multiresistant Pseudomonas aeruginosa.
Pediatr Pulmonol, (1991), pp. 279
[20.]
F.J. McLaughlin, W.J. Matthews Jr., D.J. Strieder, B. Sullivan, A. Taneja, P. Murphy, et al.
Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin and azlocillin-placebo.
J Infect Dis, 147 (1983), pp. 559-567
[21.]
R. Gold, A. Overmeyer, B. Knie, P.C. Fleming, H. Levison.
Controlled trial of ceftazidime versus ticarcillin and tobramycin in the. treatment of acute respiratory exacerbations in patients with cystic fibrosis.
Pediatr Infect Dis, 4 (1985), pp. 172-177
[22.]
M.A. Jackson, H. Kusmiesz, S. Shelton, C. Prestidge, R.I. Kramer, J.D. Nelson.
Comparison of piperacillin vs Ticarcillin Plus tobramycin in the treatment of acute respiratory exacerbations of cystic fibrosis..
Pediatr Infect Dis, 5 (1986), pp. 440-443
[23.]
J.L. Burns.
Treatment of cepacia: in search of the magic bullet [resumen].
Pediatr Pulmonol, (1997), pp. 90
[24.]
T. Jensen, S.S. Pedersen, N. Hoybi, C. Koch.
Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.
Eur J Clin Microbiol, 6 (1987), pp. 618-622
[25.]
E. Rey, J.M. Treluyer, G. Pons.
Drug disposition in cystic fibrosis.
Clin Pharmacokinet, 35 (1998), pp. 313-329
[26.]
D.J. Touw.
Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis.
Pharm World Sci, 20 (1998), pp. 149-160
[27.]
P.M. Mendelman, A.L. Smith, J. Levy, A. Weber, B.R. Ramsey, R. Davis.
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis.
Am Rev Respir Dis, 132 (1985), pp. 761-765
[28.]
R.C. Stern.
Inpatients treatment of cystic fibrosis pulmonary disease..
Treatment of the hospitalized cystic fibrosis patient., pp. 79-133
[29.]
P.J. Wood, L.L. Ioannides-Demos, S.C. Li, T.J. Williams, B. Hitkey, W.J. Spicer, et al.
Minimisation of aminoglycoside toxicity inpatients. with cystic fibrosis.
Thorax, 51 (1996), pp. 369-373
[30.]
R.D. Bates, M.C. Ionannides, W.J. Jones, K. McCoy, G. Young, A. Cox, et al.
Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis..
Chest, 112 (1997), pp. 1208-1213
[31.]
P. Vic, S. Ategbo, D. Turk, M.O. Husson, V. Launay, G.A. Loeuille, et al.
Efficacy, tolerance, and pharmacokinetics of once daily tobramicyn for pseudomonas exacerbations in cystic fibrosis.
Arch Dis Child, 78 (1998), pp. 536-539
[32.]
S.P. Conway, M.N. Pond, A. Watson, C. Etherington, H.L. Robey, M.H. Goldman.
Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.
Thorax, 52 (1997), pp. 987-993
[33.]
M.J. Ledson, M.J. Gallager, C. Cowperthwaite, R.P. Convery, M.J. Walsahaw.
Four years’ experience of intravenous colomycin in an. adult cystic fibrosis unit.
Eur Respir J, 12 (1998), pp. 592-594
[34.]
S.M. Rosenberg, C.M. Schramm.
Predictive value of pulmonary function testing during pulmonary exacerbations in cystic fibrosis.
Pediatr Pulmonol, 16 (1993), pp. 227-235
[35.]
P. Cahen, M. Le Bourgeois, C. Delacourt, C. Custère, P. Nicaise, J. De Blic, et al.
Serum bactericidal test as a prognostic indicator in. acute pulmonary exacerbations of cystic fibrosis.
Pediatrics, 91 (1993), pp. 451-455
[36.]
G.B. Winnie, R.G. Cowan, N.A. Wade.
Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis.
J Pediatr., 114 (1989), pp. 309-314
[37.]
J.E. Van Wye, M.S. Collins, M. Baylor, J.E. Pennington, Y.P. Hsu, V. Sampanvejsopa, et al.
Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis.
Pediatr Pulmonol, 9 (1990), pp. 7-18
[38.]
C. Braggion, L.M. Cappelletti, M. Cornacchia, L. Zanolla, G. Mastella.
Short-term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: a cross-over randomized study.
Pediatr Pulmonol, 19 (1995), pp. 16-22
[39.]
R. Arens, D. Gozal, K.J. Omlin, J. Vega, K.P. Boyd, T.G. Keens, et al.
Comparison of high frequency chest compression and convencional chest physiotherapy in hospitalized patients with cystic fibrosis..
Am J Respir Crit Care Med, 150 (1994), pp. 1154-1157
[40.]
J. Thomas, D.J. Cook, D. Brooks.
Chest physical therapy management of patients with cystic fibrosis. A meta-analysis.
Am J Respir Crit Care Med, 151 (1995), pp. 846-850
[41.]
G.J. Gropp.
Effectiveness of bronchodilators in cystic fibrosis (resumen).
Am J Med, 100 (1996), pp. 19S-29S
[42.]
R.W. Wilmott, R.S. Amin, A.A. Colin, A. Devault, A.J. Dozor, H. Eigen, et al.
Aerolized recombinant human dnase in hospitalized cystic. fibrosis patients with acute pulmonary exacerbations.
Am J Respir Crit Care Med, 153 (1996), pp. 1914-1917
[43.]
M.A. Thomson, P. Quirk, C.E. Swanson, B.J. Thomas, T.L. Holt, P.J. Francis, et al.
Nutricional growth retardation is associated with defective lung growth in cystic fibrosis: a preventable determinant of progressive pulmonary dysfunction.
Nutrition, 11 (1995), pp. 350-354
[44.]
B.W. Ramsey, P.M. Farrell, P. Pencharz.
Nutricional assessment and management in cystic fibrosis: a consensus report The Consensus Committee..
Am J Clin Nutr, 55 (1992), pp. 108-116
[45.]
R.W. Shepherd, T.I. Holt, G. Cleghorn, L.C. Ward, P. Francis.
Short term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: a controlled study, including effects of protein turnover.
Am J Clin Nutr, 48 (1988), pp. 235-239
[46.]
E.D. Allen, A.B. Mick, J. Nicol, K.S. McCoy.
Prolonged parenteral nutrition for cystic fibrosis patients.
Nut Clin Pract, 109 (1995), pp. 73-79
[47.]
J.D. Hosenpud, L.E. Bennett, B.M. Keck, B. Fiol, R.J. Novick.
The Registry of the International Society for Heart and lung Transplantation: Fourteen official report-1997.
J Heart Lung Transplant, 16 (1997), pp. 691-712
[48.]
G. Massard, H. Shennib, D. Metras, J. Camboulives, L. Viard, D.S. Mulder, et al.
Double lung transplantation in mechanically ventilated patients with cystic fibrosis..
Ann Thorac Surg, 55 (1993), pp. 1087-1091
[49.]
P.A. Flume, T.M. Egan, J.H. Westeman, L.I. Paradowski, J.R. Yankaskas, F.C. Detterberck, et al.
Lung transplantation for mechanically. ventilated patients..
J Heart Lung Transplant, 13 (1994), pp. 15-21
[50.]
J.S. Garland, Y.M. Chan, K.J. Kelly, T.B. Rice.
Outcome of infants with cystic fibrosis requiring mechanical ventilation for respiratory failure.
Chest, 96 (1989), pp. 136-138
[51.]
A.J. Piper, S. Parker, P.J. Torzillo, C.E. Sullivan, P.T.P. Bye.
Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure.
Chest, 102 (1992), pp. 846-850
[52.]
M.E. Hodson, B.P. Madden, M.H. Steven, V.T. Tsang, M.H. Yacoub.
Non-invasive mechanical ventilation for cystic fibrosis patients– apotential bridge to transplantation.
Eur Respir J, 4 (1991), pp. 524-527
[53.]
M.W. Elliot, A.K. Simonds, M.P. Carroll, J.A. Wedzicha, M.A. Branthwaite.
Domiciliary nocturnal nasal intermitent positive pressure ventilation in hypercapnic respiratory failure due to chronic obstructive lung disease: effects of sleep and quality of life.
Thorax, 47 (1992), pp. 342-348
[54.]
J.H. Conway, R.A. Hitchcock, R.C. Godfrey, M.P. Carroll.
Nasal intermitent positive pressure ventilation in acute exacerbations of chronic obstructive pulmonary disease– a preliminary study.
Respir Med, 87 (1993), pp. 387-394
[55.]
M.C. Martínez Carrasco, S. Domínguez García Cano, M.T. García-Marcos, M.I. Barrios Gómez de Agüero, M.C. Antelo Landeira.
Ventilación nasal con presión positiva continua o intermitente en pacientes con fibrosis quística y fracaso respiratorio hipercápnico.
An Esp Pediatr, (1999), pp. 79-80
Copyright © 2000. Sociedad Española de Neumología y Cirugía Torácica
